Several times a year the Center for Drug Evaluation and Research sends out an update to share information on new developments, opportunities, and initiatives in regulatory science with the goal of advancing medical product development.
2022
2021
2020
2019
2018
2017
If you have comments or questions, contact the CDER Office of Translational Sciences at OTSCommunications@fda.hhs.gov.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
